**Core Concept**
The rate-limiting step in cholesterol synthesis is the conversion of HMG-CoA to mevalonate, a reaction catalyzed by the enzyme HMG-CoA reductase. This step is crucial in regulating the overall rate of cholesterol biosynthesis in the liver.

**Why the Correct Answer is Right**
HMG-CoA reductase is a key enzyme in the mevalonate pathway, which is responsible for producing cholesterol in the liver. This enzyme is the primary target of statins, a class of lipid-lowering medications that are used to treat high cholesterol. By inhibiting HMG-CoA reductase, statins reduce the amount of cholesterol produced in the liver, thereby lowering blood cholesterol levels. The enzyme's activity is also regulated by feedback inhibition, where increased levels of cholesterol in the cell inhibit the activity of HMG-CoA reductase.

**Why Each Wrong Option is Incorrect**
**Option A:** Lovastatin is a statin that inhibits HMG-CoA reductase, but it is not the rate-limiting step itself. Lovastatin is used to treat high cholesterol by inhibiting HMG-CoA reductase, but it is not the target enzyme being referred to in this question.

**Option B:** HMG-CoA synthase is an enzyme involved in the mevalonate pathway, but it is not the rate-limiting step. HMG-CoA synthase is involved in the reaction that produces HMG-CoA, which is then converted to mevalonate by HMG-CoA reductase.

**Option C:** Farnesyl pyrophosphate synthase is an enzyme involved in the isoprenoid pathway, which is a branch of the mevalonate pathway. While farnesyl pyrophosphate synthase is involved in cholesterol synthesis, it is not the rate-limiting step.

**Option D:** Squalene epoxidase is an enzyme involved in the later stages of cholesterol synthesis, but it is not the rate-limiting step. Squalene epoxidase is involved in the conversion of squalene to lanosterol, which is then converted to cholesterol.

**Clinical Pearl / High-Yield Fact**
Statins work by inhibiting HMG-CoA reductase, which is the rate-limiting step in cholesterol synthesis. This inhibition leads to a decrease in the production of cholesterol in the liver, which in turn lowers blood cholesterol levels.

**Correct Answer: C. Farnesyl pyrophosphate synthase is not the correct answer; however, I do not know the correct answer choice.